+ All Categories
Home > Health & Medicine > Class drug therapy of shock

Class drug therapy of shock

Date post: 13-Jan-2017
Category:
Upload: raghu-prasada
View: 651 times
Download: 1 times
Share this document with a friend
55
Dr. RAGHU PRASADA M S MBBS,MD ASSISTANT PROFESSOR DEPT. OF PHARMACOLOGY SSIMS & RC. 1
Transcript
Page 1: Class drug therapy of shock

Dr. RAGHU PRASADA M SMBBS,MDASSISTANT PROFESSORDEPT. OF PHARMACOLOGYSSIMS & RC.

1

Page 2: Class drug therapy of shock

Term “choc” – French for “push” or impact wasfirst published in 1743 by the physician LeDranBelief – symptoms arose from fear or someother form of altered cerebral functionInadequate oxygen delivery to meet metabolicdemandsResults in global tissue hypoperfusion andmetabolic acidosisShock can occur with a normal blood pressureand hypotension can occur without shock

Page 3: Class drug therapy of shock

• Inadequate systemic oxygen delivery activatesautonomic responses to maintain systemic oxygendelivery• Sympathetic nervous system

• NE, epinephrine, dopamine, and cortisol release•Causes vasoconstriction, increase in HR, and

increase of cardiac contractility (cardiac output)• Renin-angiotensin axis

• Water and sodium conservation andvasoconstriction

• Increase in blood volume and blood pressure

Page 4: Class drug therapy of shock
Page 5: Class drug therapy of shock

Progression of physiologic effects as shock ensuesCardiac depressionRespiratory distressRenal failureDIC

Result is end organ failure

Page 6: Class drug therapy of shock

• History• Recent illness• Fever• Chest pain,• Abdominal pain• Comorbidities• Medications• Toxins/Ingestions• Recent hospitalization or

surgery• Baseline mental status

• Physical examination• Vital Signs• CNS – mental status• Skin – color, temp, rashes,

sores• CV – heart sounds• Resp – lung sounds, RR,

oxygen sat, ABG• GI – abd pain, rigidity,

guarding, rebound• Renal – urine output

Page 7: Class drug therapy of shock

• Infectious sourceCardiorespiratory monitorPulse oximetrySupplemental oxygenIV accessABG, lab investigations-CBC, Chemistries, Lactate

Coagulation studies, CulturesFoley catheter

Page 8: Class drug therapy of shock

CT of head/sinusesLumbar punctureWound culturesAcute abdominal seriesAbdominal/pelvic CT or USCortisol levelFibrinogen, FDPs, D-dimer

Page 9: Class drug therapy of shock

HypovolemicSepticCardiogenicAnaphylacticNeurogenicObstructive

Page 10: Class drug therapy of shock

10

Type Preload CO PVR SVR

Hemmorrhagic

Anaphylactic

Cardiogenic

Septic(Hyperdynamic)

Septic(Hypodynamic)

/

Page 11: Class drug therapy of shock

Non-hemorrhagicVomitingDiarrheaBowel obstruction,pancreatitisBurnsEnvironmental(dehydration)

HemorrhagicGI bleedTraumaMassive hemoptysisAbdominal AorticAneurysmrupture(AAA)Ectopic pregnancy,post-partum bleeding

Page 12: Class drug therapy of shock

Airway Breathing CirculationEstablish 2 large bore IVs or a central lineCrystalloids

Normal Saline or Lactate Ringers-Up to 3 litersPacked Red Blood CellsO negative or cross matchedControl any bleedingArrange definitive treatment

Page 13: Class drug therapy of shock

TBW (42 L) = 2/3 of body weight (70 kg).

ICF (28 L) = 2/3 of TBW.

ECF (14 L) = 1/3 of TBW.

Interstitial fluid (ISF, 10.5 L) = ¾ of ECF

Intravascular fluid (IVF, 3.5 L) = ¼ of ECF.

Page 14: Class drug therapy of shock

“Crystalloids”Normal saline (just NaCl).Lactated ringersPlasmalyte-balanced crystalloid solution withmultiple electrolye solutionNormosol-solution of balanced electrolytes in waterfor injection.Last 3 have K+ and other stuff (acetate, Mg++, etc.)

Page 15: Class drug therapy of shock

Crystalloids enter entire ECF: ISF (3/4 of ECF) and IVF(1/4 of ECF).3 or 4:1 for replacement of blood loss with crystalloidColloids only enter IVF (in short term– 16 hour half-time for entrance into ISF)1:1 replacement of blood loss with colloid

Page 16: Class drug therapy of shock

Blood trasfusionPacked red cells- increase O2 carrying capacityPlasma-fresh frozen plasma contains all stable

proteins-albumin, globulin and clotting factorsNormal human serum albumin-reduce edema,hypovolemic shock

Page 17: Class drug therapy of shock

DEXTRAN-isolated from beet rootInhibit rouleaux formationHYDROXYETHYL STARCH-resistant to hydrolysis byamylase, maintains blood volume longerPOLYVINYL PYROLIDINE (PVP)-synthetic water solublehydrophilic polymerGelatin polymers-HAEMACCEL-polypeptide dissolvedin electrolyteDEXTROSE-5% in water

Page 18: Class drug therapy of shock

18

Vasoactive drugs are an important pharmacologicdefense in the treatment of shock.May be required to support BP in the early stages ofshock.These agents may be needed to:

Enhance CO through the use of inotropic agentsIncrease SVR through the use of vasopressors

Page 19: Class drug therapy of shock

19

Epinephrine , β1, (β2) 2-10 µg/min

Norepinephrine , β1 0 - 2-20 µg/min

Dopamine β1, DR, (α ) 1 - 30

Dobutamine β1, β2 2 - 20

Phenylphrine 20-200µg/min

Vasopressin Angiotensin III 5 - 20

Amrinone PDI 2 -15

Drug Receptor CO SVR Dose Range

0 -

(µg/kg/min)

1

0

Page 20: Class drug therapy of shock

20

Nifedipine 0 - 0.5 - 10

Nitroglycerin 0 - 3 - 5

Nitroprusside 0 - 0.5 - 5

Prostacyclin 10 - 40

2

Drug CO SVR Dose Range

(µg/kg/min)

Page 21: Class drug therapy of shock

21

An endogenous precursor of norepinephrine withmultiple dose-related effectsstimulates alpha, beta and dopaminergic receptors.Low Dose (0.5 - 3 µg/kg/min)

Predominantly dopaminergic (DR) effectsEnhanced blood flow to renal and splanchnic beds

Moderate Dose (5 -10 µg/kg/min)Positive inotropic effects (1)

High Dose (>10 µg/kg/min)a-actions (vasoconstriction)

Page 22: Class drug therapy of shock

DRUG Common UsesPhenylephrine Septic Shock, neurogenic

shock

Norepinephrine Septic shock

Epinephrine Anaphylaxis, ACLS, septicshock

Dopamine Renal Insufficeny, septicshock, cardiogenic shock

Dobutamine Cardiogenic shock (CS)

Isoproterenol bradycardia due to heartblock, effects HR

Milrinone Cardiogenic shock- in thosewho don’t respond todobutamine

Page 23: Class drug therapy of shock

Epinephrine—catecholamine. Low doses stimulatesbeta receptors (so increases CO), causesbronchodilation as well. Larger doses act on alphareceptors.

Drug of choice in anaphylaxis. Prevents release ofhistamine, so reverses vasodilation andbronchoconstriction.

Can be given IV, subcut or even via ETT.

Page 24: Class drug therapy of shock

Isoxsuprine(isoproterenol)—synthetic catecholamine.Works exclusively on beta receptors. Increases heartrate, myocardial contractility and variable BP effects.

Limited usefulness as vasopressor. Increases myocardialoxygen consumption and decreases coronary flow.Causes cardiac dysrhythmias.

Page 25: Class drug therapy of shock

Milrinone—used in combination with other agents incardiogenic shock.Increases cardiac output and decreases SVR withoutincreasing heart rate or myocardial oxygenconsumption.Improved CO then increases renal perfusion, thusurinary output with decrease in circulating volume anddecreased cardiac workload.

Page 26: Class drug therapy of shock

Norepinephrine—catecholamine.Primarily alpha 1 stimulation but also beta1 receptors.Useful in cardiogenic and septic shock.Does cause reduced renal blood flow so limits its longterm use.Phenylephrine—adrenergic that stimulates alphareceptors. Longer duration of action thanepinephrine. Reduction of renal and mesenteric bloodflow limits prolonged use.

Page 27: Class drug therapy of shock

Neosynephrine (phenyleprine)—adrenergic thatstimulates alpha receptors. Longer duration ofaction than epinephrine. Reduction of renal andmesenteric blood flow limits prolonged use.

Page 28: Class drug therapy of shock

Two or more of Criteria-Systemic InflammatoryResponse Syndrome (SIRS)

Temp > 38 or < 36 CHR > 90RR > 20WBC > 12,000 or < 4,000

Plus the presumed existence of infectionBlood pressure can be normal!

Page 29: Class drug therapy of shock

Sepsis plus refractory hypotensionAfter bolus of 20-40 mL/Kg patient still has one ofthe following:

SBP < 90 mm HgMAP < 65 mm HgMAP = [(2 x diastolic)+systolic] / 3

Page 30: Class drug therapy of shock

High feverDiffuse rash with desquamation on the palms andsoles over subsequent 1-2 weeksHypotension (may be orthostatic) and evidence ofinvolvement of 3 other organ systems

Streptococcal TSS more frequently presents with focalsoft tissue inflammation and less commonly isassociated with diffuse rash.Streptococcus pyogenes (group A Streptococcus)S aureus

Page 31: Class drug therapy of shock
Page 32: Class drug therapy of shock

• 2 large bore IVs• NS IVF bolus- 1-2 L wide open (if no

contraindications)• Supplemental oxygen• Empiric antibiotics, based on suspected source, as

soon as possibleAntibiotics- Survival correlates with how quickly thecorrect drug was givenCover gram positive and gram negative bacteria

Page 33: Class drug therapy of shock

Zosyn(piperacillin+ tazobactum) 3.375 grams IV andceftriaxone 1 gram IV orImipenem 1 gram IV

Add additional coverage as indicatedPseudomonas- Gentamicin or CefepimeMRSA- VancomycinIntra-abdominal or head/neck anaerobic infections-Clindamycin or MetronidazoleAsplenic- Ceftriaxone for N. meningitidis, H. infuenzaeNeutropenic – Cefepime or Imipenem

Page 34: Class drug therapy of shock

Vasoactive Drugs in Sepsis and Usual Hemodynamic Responses

Drug DoseCardiacOutput

BloodPressure

SystemicVascularResistance

Dopamine* 2.5-20 mcg/kg/min + + +

Norepinephrine† 0.05-2 mcg/kg/min + ++ ++

Epinephrine 0.05-2 mcg/kg/min ++ ++ +

Phenylephrine 2-10 mcg/kg/min - ++ ++

Dobutamine‡ 2.5-10 mcg/kg/min + +/- -

Page 35: Class drug therapy of shock

• Signs:• Cool, mottled skin• Tachypnea• Hypotension• Altered mental status• Narrowed pulse

pressure• Rales, murmur

• Defined as:• SBP < 90 mmHg• CI < 2.2 L/m/m2

• PCWP > 18 mmHg• Pulmonary Arterial

Wedge pressure

Page 36: Class drug therapy of shock

AMISepsisMyocarditisMyocardial contusionAortic or mitral stenosis, HCMAcute aortic insufficiency

Page 37: Class drug therapy of shock

Often after ischemia, loss of LV functionLose 40% of LV clinical shock ensues

CO reduction lactic acidosis, hypoxiaStroke volume is reduced

Tachycardia develops as compensationIschemia and infarction worsens

Page 38: Class drug therapy of shock

Goals- Airway stability and improving myocardialpump functionCardiac monitor, pulse oximetrySupplemental oxygen, IV accessIntubation will decrease preload and result inhypotension -fluid bolus

Page 39: Class drug therapy of shock

AMIAspirin, beta blocker, morphine, heparinIf no pulmonary edema, IV fluid challengeIf pulmonary edema

Dopamine – will ↑ HR and thus cardiac workDobutamine – May drop blood pressureCombination therapy may be more effective

PCI(Percutaneous Coronary Intervention) or thrombolyticsRV infarct

Fluids and Dobutamine (no NTG)Acute mitral regurgitation or VSD

Pressors (Dobutamine and Nitroprusside)

Page 40: Class drug therapy of shock

Correct hypotension:Fluid resuscitation to correct hypovolemiaInotropic or Vasopressor support:

DobutamineMilrinoneNorepinephrineDopamineEpinephrine

OxygenationIf MI – ASA, Heparin, and RevascularizationIf arrhythmia – correct arrhythmiaIf extracardiac abnormality – reverse or treat cause

Page 41: Class drug therapy of shock

Clinical Signs: Shock, Hypoperfusion, CHF, Acute Pulm EdemaMost likely major underlying disturbance?

Acute PulmonaryEdema

Hypovolemia Low-outputcardiogenic shock

Arrhythmia

AdministerFurosemideMorphine

Oxygen intubationNitroglycerin

DopamineDobutamine

AdministerFluids

Blood transfusionsCause-specificinterventions Check Blood Pressure

Bradycardia

Tachycardia

Check Blood Pressure

Systolic BP(>100 mm Hg)

Systolic BP(NO

signs/symptoms of shock)

Systolic BP(signs/symptoms

of shock)

Systolic BP (<70 mmHg + signs/symptoms

of shock)

See Sec. 7.7 inACC/AHA Guidelines

for patients withSTEMI

ACEInhibitors

Nitroglycerin Dobutamine Dopamine Norepinephrine

Systolic BP(>100 mm

Hg)

Further Diagnostic/Therapeutic Considerations (for non-hypovolemicshock)

Diagnostic / TherapeuticPulmonary artery catheter, Intra-aortic balloon pump,echo, angiography, etc Reperfusion revascularization 41

Page 42: Class drug therapy of shock

• Anaphylaxis – a severe systemic hypersensitivityreaction characterized by multisysteminvolvement• IgE mediated

• Anaphylactoid reaction – clinicallyindistinguishable from anaphylaxis, do notrequire a sensitizing exposure• Not IgE mediated

Page 43: Class drug therapy of shock

Pruritus, flushing, urticaria appear

Throat fullness, anxiety, chest tightness,shortness of breath and lightheadedness

Finally- Altered mental status, respiratorydistress and circulatory collapse

Page 44: Class drug therapy of shock

ABC’sAngioedema and respiratory compromise requireimmediate intubation

IV, cardiac monitor, pulse oximetryIVFs, oxygenEpinephrineSecond line

CorticosteriodsH1 and H2 blockers

Page 45: Class drug therapy of shock

Epinephrine0.3 mg IM of 1:1000Repeat every 5-10 min as neededCaution with patients taking beta blockers- cancause severe hypertension due to unopposedalpha stimulationFor CV collapse, 1 mg IV of 1:10,000If refractory, start IV drip

Page 46: Class drug therapy of shock

CorticosteroidsMethylprednisolone 125 mg IVPrednisone 60 mg PO

AntihistaminesH1 blocker- Diphenhydramine 25-50 mg IVH2 blocker- Ranitidine 50 mg IV

BronchodilatorsAlbuterol nebulizerAtrovent nebulizerMagnesium sulfate 2 g IV over 20 minutes

GlucagonFor patients taking beta blockers and with refractoryhypotension1 mg IV q5 minutes until hypotension resolves

Page 47: Class drug therapy of shock

• Occurs after acute spinal cord injury• Sympathetic outflow is disrupted leaving

unopposed vagal tone• Results in hypotension and bradycardia• Spinal shock- temporary loss of spinal reflex activity

below a total or near total spinal cord injury (not thesame as neurogenic shock, the terms are notinterchangeable)

Page 48: Class drug therapy of shock

Loss of sympathetic tone results in warm and dry skinShock usually lasts from 1 to 3 weeksAny injury above T1 can disrupt the entire sympatheticsystem

Higher injuries = worse paralysis

Page 49: Class drug therapy of shock

A,B,CsRemember c-spine precautions

Fluid resuscitationKeep MAP at 85-90 mm Hg for first 7 daysThought to minimize secondary cord injuryIf crystalloid is insufficient use vasopressors

Search for other causes of hypotensionFor bradycardia

AtropinePacemaker

Page 50: Class drug therapy of shock

MethylprednisoloneUsed only for blunt spinal cord injuryHigh dose therapy for 23 hoursMust be started within 8 hoursControversial- Risk for infection, GI bleed

Page 51: Class drug therapy of shock

Tension pneumothoraxAir trapped in pleural space with 1 way valve,air/pressure builds upMediastinum shifted impeding venous returnChest pain, SOB, decreased breath soundsConfirmation -CXRRx: Needle decompression, chest tube

Page 52: Class drug therapy of shock

Cardiac tamponadeBlood in pericardial sac prevents venous return toand contraction of heartRelated to trauma, pericarditis, MIBeck’s triad: hypotension, muffled heart sounds, JVDDiagnosis: large heart CXR, echoRx: Pericardiocentisis

Page 53: Class drug therapy of shock

Pulmonary embolismVirchow’s triad: Hypercoagulability. Hemodynamicchanges (stasis, turbulence) Endothelialinjury/dysfunction.Signs: Tachypnea, tachycardia, hypoxiaLow risk: D-dimerHigher risk: CT chestRx: Heparin, consider thrombolytics

Page 54: Class drug therapy of shock

Aortic stenosisResistance to systolic ejection causes decreasedcardiac functionChest pain with syncopeSystolic ejection murmurDiagnosed with echoVasodilators (NTG) will drop pressure!Rx: Valve surgery

Page 55: Class drug therapy of shock

Download slides fromAuthorstream-raghuprasada

Slideshare-raghuprasadaYoutube-raghuprasada


Recommended